Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Anti-Inflammatory Drugs Market Poised To Hit $252.87 Billion By 2030 With A 10.6% CAGR
The market size for anti-inflammatory drugs has shown rapid expansion over recent years. This sector is projected to grow from $152.08 billion in 2025 to $168.74 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.0%. The historical growth of this market can be linked to factors such as arthritis prevalence, NSAID usage, hospital prescribing, the burden of autoimmune diseases, and the adoption of steroid therapy.
The anti-inflammatory drugs market size is anticipated to undergo swift expansion over the coming years. This sector is projected to reach $252.87 billion by 2030, displaying a compound annual growth rate (CAGR) of 10.6%. The expansion during the forecast period is attributable to innovation in biologics, the increasing adoption of biosimilars, an aging global population, the rising prevalence of autoimmune diseases, and the integration of precision medicine. Significant developments expected in this period include the wider utilization of biologics and biosimilars, the broadening of treatment options for chronic inflammatory conditions, a movement towards more targeted anti-inflammatory treatments, the development of topical and localized formulations, and a heightened emphasis on long-term safety considerations.
Get A Free Sample Report With In-Depth Market Insights:
Anti-Inflammatory Drugs Market Demand Drivers Opening New Revenue Streams
The increasing occurrence of arthritis is anticipated to boost the growth of the anti-inflammatory drugs market in the future. Arthritis is defined as the inflammation of one or more joints, resulting in pain, swelling, and stiffness that can intensify with age. The growing number of arthritis cases is mainly attributed to aging populations, as the natural deterioration of joints increases with age, leading to a higher likelihood of developing arthritis. Anti-inflammatory drugs assist in managing arthritis by diminishing joint inflammation and pain, thereby allowing patients to uphold better mobility and execute daily tasks more effortlessly, ultimately enhancing their overall quality of life. For instance, in July 2024, information from Restored CDC, a US-based nonprofit health information body, indicated that approximately 21.2% of adults aged 18 and older in the US received an arthritis diagnosis in 2023. Thus, the escalating prevalence of arthritis is propelling the expansion of the anti-inflammatory drugs market.
Anti-Inflammatory Drugs Market Segment Analysis And Revenue Potential
The anti-inflammatory drugs market covered in this report is segmented –
1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes
2) By Route of Administration: Parenteral, Oral, Topical, Inhalation
3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Steroids: Corticosteroids, Mineralocorticoids
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors
3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars
4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
Anti-Inflammatory Drugs Market Trends Powering Strategic Industry Growth
Major companies in the anti-inflammatory drugs market are focusing on developing innovative solutions, such as advanced corticosteroid alternatives, to meet the increasing demand for safer long-term anti-inflammatory therapies. A next-generation corticosteroid alternative is a treatment engineered to maintain glucocorticoid anti-inflammatory effects while reducing the adverse outcomes commonly associated with traditional steroids, including bone loss, growth suppression, and weight gain. For instance, in October 2023, Santhera Pharmaceuticals, a Switzerland-based specialty pharmaceutical company, received US FDA approval for AGAMREE (vamorolone). AGAMREE is an oral dissociative steroid designed to provide anti-inflammatory activity with fewer steroid-related side effects by selectively modulating glucocorticoid receptor pathways and stabilizing cell membranes. Compared to traditional corticosteroids like prednisone and deflazacort, it offers a more favorable safety profile while retaining therapeutic benefits. It is used to manage chronic muscle inflammation in children aged two years and older with Duchenne muscular dystrophy.
Anti-Inflammatory Drugs Market Key Players Shaping Industry Direction
Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited
View The Full Anti-Inflammatory Drugs Market Report:
Anti-Inflammatory Drugs Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model